189 related articles for article (PubMed ID: 24343831)
1. FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials.
Itani KM; Shorr AF
Clin Infect Dis; 2014 Jan; 58 Suppl 1():S4-9. PubMed ID: 24343831
[TBL] [Abstract][Full Text] [Related]
2. New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good.
Corey GR; Stryjewski ME
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S469-76. PubMed ID: 21546623
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.
Beresford E; Biek D; Jandourek A; Mawal Y; Riccobene T; Friedland HD
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):123-35. PubMed ID: 24494793
[TBL] [Abstract][Full Text] [Related]
4. US FDA draft Guidance Standard for Clinical Trial Imaging Endpoints: more than just imaging?
Walovitch RC; Chokron P; Agarwal S
Biomark Med; 2012 Dec; 6(6):839-47. PubMed ID: 23227850
[TBL] [Abstract][Full Text] [Related]
5. Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
Basch E; Trentacosti AM; Burke LB; Kwitkowski V; Kane RC; Autio KA; Papadopoulos E; Stansbury JP; Kluetz PG; Smith H; Justice R; Pazdur R
Cancer; 2014 Mar; 120(5):761-7. PubMed ID: 24375398
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials in neonatal sepsis.
Oeser C; Lutsar I; Metsvaht T; Turner MA; Heath PT; Sharland M
J Antimicrob Chemother; 2013 Dec; 68(12):2733-45. PubMed ID: 23904558
[TBL] [Abstract][Full Text] [Related]
7. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
[TBL] [Abstract][Full Text] [Related]
8. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
Leon MB; Piazza N; Nikolsky E; Blackstone EH; Cutlip DE; Kappetein AP; Krucoff MW; Mack M; Mehran R; Miller C; Morel MA; Petersen J; Popma JJ; Takkenberg JJ; Vahanian A; van Es GA; Vranckx P; Webb JG; Windecker S; Serruys PW
J Am Coll Cardiol; 2011 Jan; 57(3):253-69. PubMed ID: 21216553
[TBL] [Abstract][Full Text] [Related]
9. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB;
EuroIntervention; 2012 Nov; 8(7):782-95. PubMed ID: 23022744
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Dancey JE; Dobbin KK; Groshen S; Jessup JM; Hruszkewycz AH; Koehler M; Parchment R; Ratain MJ; Shankar LK; Stadler WM; True LD; Gravell A; Grever MR;
Clin Cancer Res; 2010 Mar; 16(6):1745-55. PubMed ID: 20215558
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
12. Assessing tumor-related signs and symptoms to support cancer drug approval.
Williams G; Pazdur R; Temple R
J Biopharm Stat; 2004 Feb; 14(1):5-21. PubMed ID: 15027497
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
Cleeland CS; Sloan JA;
J Pain Symptom Manage; 2010 Jun; 39(6):1077-85. PubMed ID: 20538189
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.
Cates JE; Mitrani-Gold FS; Li G; Mundy LM
Antimicrob Agents Chemother; 2015 Aug; 59(8):4510-20. PubMed ID: 25987628
[TBL] [Abstract][Full Text] [Related]
15. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB;
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):6-23. PubMed ID: 23084102
[TBL] [Abstract][Full Text] [Related]
16. Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.
Talbot GH; Powers JH; Fleming TR; Siuciak JA; Bradley J; Boucher H;
Clin Infect Dis; 2012 Oct; 55(8):1114-21. PubMed ID: 22744885
[TBL] [Abstract][Full Text] [Related]
17. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Hicks KA; Mahaffey KW; Mehran R; Nissen SE; Wiviott SD; Dunn B; Solomon SD; Marler JR; Teerlink JR; Farb A; Morrow DA; Targum SL; Sila CA; Hai MTT; Jaff MR; Joffe HV; Cutlip DE; Desai AS; Lewis EF; Gibson CM; Landray MJ; Lincoff AM; White CJ; Brooks SS; Rosenfield K; Domanski MJ; Lansky AJ; McMurray JJV; Tcheng JE; Steinhubl SR; Burton P; Mauri L; O'Connor CM; Pfeffer MA; Hung HMJ; Stockbridge NL; Chaitman BR; Temple RJ;
Circulation; 2018 Feb; 137(9):961-972. PubMed ID: 29483172
[TBL] [Abstract][Full Text] [Related]
18. Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research Consortium.
Seltzer JH; Turner JR; Geiger MJ; Rosano G; Mahaffey KW; White WB; Sabol MB; Stockbridge N; Sager PT
Am Heart J; 2015 Feb; 169(2):197-204. PubMed ID: 25641528
[TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Jorgenson MR; DePestel DD; Carver PL
Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
[TBL] [Abstract][Full Text] [Related]
20. SNM submits imaging endpoint comments to FDA.
Clarke B; Merrill J
J Nucl Med; 2012 Feb; 53(2):13N. PubMed ID: 22302969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
